Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and inclusion in cancer clinical trials.

In spring 2021, ACCC and Harborside hosted a Virtual Summit to Define on the Role Oncology Advanced Practitioners in Equitable Cancer Care Delivery. Each summit session focused one specific domain of care delivery—Care Coordination and Communication; Clinical Trials; and Acknowledging and Mitigating Implicit Bias. Look for more on the Summit findings coming soon to the ACCC website.

Guest:

Colleen Lewis, MSN, ANP-BC, AOCNP

Director of Clinical Operations, Phase I Program;

Interim Director, Infusion Center Clifton

The Winship Cancer Institute of Emory University

Related Content:

ACCC Community Oncology Research Institute

ASCO-ACCC Initiative to Increase Racial and Ethnic Diversity in Clinical Trials

Real World Lessons from COVID-19 [Video Podcast]

Ep 52: End of Life Disparities [Podcast]

Ep 51: Cultural Humility and Sensitivity [Podcast]

Ep 49: Building Trust with Marginalized Groups [Mini-Podcast]

In Pursuit of Equity: Diversity in Clinical Research Participation [Webinar]

Practical Solutions to Better Engage Cancer Professionals with Communities of Color [Webinar]

Implementation of a Health Disparities & Equity Program at the Duke Cancer Institute,

Paving the Way for APPs in Clinical Research

[Abstract 95] Role of Oncology Advanced Practitioners to Enhance Clinical Research

Research Review: Making Clinical Trials More Inclusive, Diverse, Accessible, and Representative

Phase 1 Clinical Trials in the Elderly: Enrollment Challenges

Bias and stereotyping among research and clinical professionals: perspectives on minority recruitment for oncology clinical trials